Activity value 76india Buyer&Supplier,Last transaction date:
2025-11-14
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for good faith pharma imp exp from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 82 transactions, with a transaction quantity of 82474 and a transaction weight of 0.
YearTransactionsQuantityWeight
20247858360
202582824740
Bill of lading data
<
1/15
>
Trade date
2025/11/14
B/L No.
——
Suppliers
good faith pharma imp exp
Buyers
lyudmil stanev
POLs
mumbai (ex bombay)
PODs
raleigh
Supply area
India
Purchas area
Bulgaria
Weight
——
Amount
325548.11
Hs code
30049099
Product tags
human normal immunoglobulin,bat
Product description
GLOBUCEL 10MG HUMAN NORMAL IMMUNOGLOBULIN BATCH NO 97130177
Expand
Trade date
2025/10/22
B/L No.
——
Suppliers
good faith pharma imp exp
Buyers
nikolai milekhin
good faith pharma imp exp is india Buyer&Supplier,
and primarily engages in the import and export business of products such as bat,promethazine,phenergan syrup.
According to the 52wmb.com global trade database, as of 2025-11-14, the company has completed 1522 international trades,
with its main trading regions covering england,saudi arabia,united arab emirates etc.
The core products include HS30049099,HS30049031,HS30049091 etc,
often transported via sahar air cargo acc inbom4,port bombay air, port sahar air etc,
and its main trading partners are anmol chawla,a singh,akash bagga.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on good faith pharma imp exp is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.